News by

Analysts See $0.75 EPS for Leidos Holdings, Inc. (LDOS)

Vivian Currie

Investors sentiment decreased to 0.97 in Q4 2016. Its down 1.93, from 2.9 in 2016Q3. It dropped, as 41 investors ...

Karyopharm Therapeutics Inc (KPTI) Analysts See $-0.63 EPS

Vivian Currie

Investors sentiment increased to 2.4 in 2016 Q4. Its up 0.88, from 1.52 in 2016Q3. It improved, as 5 investors ...

EPS for Intra-Cellular Therapies Inc (ITCI) Expected At $-0.74

Vivian Currie

Investors sentiment increased to 1.46 in Q4 2016. Its up 0.52, from 0.94 in 2016Q3. It improved, as 25 investors ...

EPS for Cooper-Standard Holdings Inc (CPS) Expected At $2.78

Vivian Currie

Investors sentiment decreased to 1.25 in Q4 2016. Its down 0.62, from 1.87 in 2016Q3. It dropped, as 18 investors ...

$-0.39 EPS Expected for Corium International Inc (CORI)

Vivian Currie

Investors sentiment increased to 0.86 in Q4 2016. Its up 0.17, from 0.69 in 2016Q3. It increased, as 5 investors ...

EPS for Ball Corporation (BLL) Expected At $0.55

Vivian Currie

Investors sentiment decreased to 0.98 in 2016 Q4. Its down 0.34, from 1.32 in 2016Q3. It dived, as 43 investors ...

Archrock Partners LP (APLP) Analysts See $0.08 EPS

Vivian Currie

Analysts await Archrock Partners LP (NASDAQ:APLP) to report earnings on August, 3. They expect $0.08 earnings per share, down 61.90 ...

ACADIA Pharmaceuticals Inc. (ACAD) EPS Estimated At $-0.71

Vivian Currie

Investors sentiment decreased to 1.06 in Q4 2016. Its down 0.14, from 1.2 in 2016Q3. It fall, as 42 investors ...

Next Page »
NOTE: This sidebar is empty, click here and add widgets to the Sidebar (Archives) widgetised area.